drugset / Trial / NCT06007066

HSK16149 for Perioperative Analgesia in Orthopedic Surgery

NCT06007066

Phase 2 Completed 235 enrolled Haisco Pharmaceutical Group Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will compare the effect and safety of HSK16149 with placebo on perioperative analgesia in orthopedic surgery, and explore the dosage of HSK16149 capsules for orthopedic analgesia during perioperative period.

Timeline

Start
2023-03-08
Primary completion
2023-06-12
Completion
2023-07-05

Drugs

EvaluationDrugModalityDoseRoute
Subject HSK16149 Unknown 40 mg Oral
Subject HSK16149 Unknown 60 mg Oral

Indications

No indication recorded.